The Aging Brain: Navigating Cognition, Mental Health and Psychopharmacological Treatment
OVERVIEW
The Aging Brain: Navigating Cognition, Mental Health and Psychopharmacological Treatment is organized by University of Miami Miller School of Medicine Division of Continuing Medical Education and will be held from Mar 03 - 07, 2025 at Grand Beach Hotel, Miami Beach, Miami, Florida, United States of America.
Description:
Brain health is recognized as an essential part of successful aging. To promote longevity and quality of life, brain functioning across cognitive, socio-emotional, and behavioral domains allows a person to realize their full potential over their lifetime. The prevalence of cognitive disorders is increasing rapidly as people live longer. Reducing the risk of cognitive disorders such as Alzheimer’s Disease and Related Dementias (ADRD) is as essential to the clinician as reducing hypertension and diabetes in reducing cardiovascular disease. This course is designed to educate the practitioners and equip them with essential knowledge and state-of-the-art scientific methods to diagnose Alzheimer’s Disease and Related Dementias (ADRD) at its earliest stages and assist patients and their loved ones. Drawing on the presenters’ vast scientific and clinical expertise, the participants will be able to differentiate different cognitive syndromes and the etiological underpinnings of various clinical presentations. In addition, the participant will be familiarized with state-of-the-art neuropsychological and novel neuroimaging and plasma-based biomarkers methods to detect the earliest stages of Alzheimer’s Disease. This presentation will also provide essential information about emerging pharmacological agents in the treatment and management of Alzheimer’s Disease and Related Dementias, identifying the importance of cultural diversity and the importance of working with family members.
ACCME Objectives:
- Differentiate between normal cognitive aging, mild cognitive impairment (MCI), and clinical dementia;
- Discuss how to identify the underlying brain disorders causing clinical cognitive impairment in older adults;
- Identify the evidence-based, emerging brain biomarkers in cognitive disorders that help to diagnose at-risk older individuals for Alzheimer’s Disease and Related Dementias (ADRD);
- Identify the role of traditional and novel cognitive neuropsychological testing in early diagnosis of cognitive disorders in older individuals;
- Differentiate Alzheimer’s Disease from non- Alzheimer’s Disease pathology;
- Describe current pharmacological and nonpharmacological approaches to the treatment of Alzheimer’s Disease and Related Dementias (ADRD);
- Understand the emerging and promising agents in the treatment and management of early Alzheimer’s disease (AD);
- Understand geriatric psychopharmacology and how to optimally treat the more challenging geriatric mental health conditions;
- Describe the promotion of brain health and longevity through evidence-based prevention.
APA Objectives:
- Differentiate between normal cognitive aging, mild cognitive impairment (MCI), and clinical dementia;
- Discuss how to identify the underlying brain disorders causing clinical cognitive impairment in older adults;
- Identify the evidence-based, emerging brain biomarkers in cognitive disorders that help to diagnose at-risk older individuals for Alzheimer’s Disease and Related Dementias (ADRD);
- Identify the role of traditional and novel cognitive neuropsychological testing in early diagnosis of cognitive disorders in older individuals;
- Differentiate Alzheimer’s Disease from non- Alzheimer’s Disease pathology;
- Describe current pharmacological and nonpharmacological approaches to the treatment of Alzheimer’s Disease and Related Dementias (ADRD);
- Understand the emerging and promising agents in the treatment and management of early Alzheimer’s disease (AD);
- Understand geriatricccand how to optimally treat the more challenging geriatric mental health conditions;
- Describe the promotion of brain health and longevity through evidence-based prevention.
KEY DATES
03 Mar, 2025
Event Start Date
07 Mar, 2025
Event End Date
ACCREDITATION & CREDITS
Accreditation
Physician Credit
The University of Miami Leonard M. Miller, School of Medicine, designates these live winter activities for a maximum of 15 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.
Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits® (ECMECs®). Information on the process of converting AMA PRA Category 1 Credits™ to ECMECs®.
Psychologists
The University of Miami Leonard M. Miller School of Medicine is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. The University of Miami Leonard M. Miller School of Medicine maintains responsibility for this program and its content. 15.00 CE credits will be awarded to psychologists for attendance at these seminars.
Nurse Practitioners and Registered Nurses
These activities have been submitted to ANA Massachusetts for approval to award contact hours. ANA Massachusetts is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Social Workers
Application for social work continuing education credit has been submitted.
National Board of Certified Counselors
University of Miami Miller School of Medicine Department of Psychiatry and Behavioral Sciences has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7482. Programs that do not qualify for NBCC credit are clearly identified. University of Miami Miller School of Medicine Department of Psychiatry and Behavioral Sciences is solely responsible for all aspects of the programs.
TARGET AUDIENCE
PhysicianNursingPharmacistPhysician AssistantResearchersResidentsNeurologistsFamily MedicineIntegrative Medicine PhysiciansNursesInternal MedicineInternistSocial WorkersNeurosurgeonsMedical StudentsGeriatricsNeuropsychologistsIntensivistsPsychiatristsPediatricsNurse PractitionersFellowsPsychologistsPediatric NeurologistsSPECIALITIES
Family MedicineGeriatricsIntegrative MedicineInternal MedicineNeurologyPediatricsPreventive MedicinePsychiatryPsychologyNeurosurgerySUGGESTED HOTELS
CONFERENCE VENUE
CANCELLATION & REFUND POLICY
Refunds, less an administrative fee of $100, will be issued for all cancellations received two weeks before the start of the course. Refund requests must be received by email. No refund will be issued should cancellation occur less than two weeks prior. “No shows” are subject to the full course fee, and no refunds will be issued once the conference has started.
RELATED CONFERENCES & LIVE WEBINARS
By eMedEd, Inc.
Sep 25 - 26, 2027 | Orlando, Florida, USA
Neurology
10 AMA PRA Category 1 Credits™
...
...
Quick Links